Novelix Pharmaceuticals Ltd — Important, 15-08-2025: Company Update

Novelix Pharmaceuticals has completed the allotment of 15.45 lakh new equity shares at Rs. 20 each, stemming from the conversion of an equal number of warrants by promoter and non-promoter investors. This strategic move, which brought in Rs. 2.3175 crore, significantly boosts the company's capital reserves. Consequently, the paid-up equity capital has increased from Rs. 12.935 crore to Rs. 14.48 crore. This strengthens Novelix's financial position and highlights continued investor support.